Germ cells having inactivated endogenous immunoglobulin genes, and transgenic animals derived therefrom
US8703485B2 · kind B2 · utility
18Cited by
18References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 30, 2008 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Oct 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to transgenic animals lacking endogenous Ig and capable of producing transgenic antibodies, as well as methods of making the same. The invention further relates to methods for producing transgenic antibodies in such animals, and transgenic antibodies so produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.